Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudouridine-5'-phosphatase (PUDP) is an enzyme encoded by the PUDP gene (*HDHD1/HDHD1A*) on the X chromosome. It catalyzes the dephosphorylation of pseudouridine 5′-phosphate, a modified nucleotide and potential intermediate in ribosomal RNA (rRNA) degradation. The removal of the phosphate allows pseudouridine to be excreted intact in urine. While the primary substrate is pseudouridine 5'-phosphate, the enzyme can also act on other phosphorylated metabolites but with lower affinity. Mutations or deletions in this gene have been associated with X-linked ichthyosis and tricuspid valve stenosis[8][2][7][6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudouridine-5'-phosphatase (PUDP).